Retatrutide is a weight loss aid that is currently a peptide for research purposes. Animal and human trials have been completed with good results .
Does retatrutide burn fat ?
Yes, retatrutide is designed to promote fat burning. It's a triple agonist, meaning it targets three hormone receptors (GLP-1, GIP,and glucagon) that play a role in appetite, metabolism, and fat storage. By interacting with these receptors, retatrutide helps reduce appetite, increase metabolism, and potentially enhance the body's ability to burn fat. Early clinical trials have shown significant weight loss and fat reduction in participants taking retatrutide
Side effects
Retatrutide, a medication currently in clinical trials for weight loss, is known to cause gastrointestinal side effects similar to other GLP-1 receptor agonists. Common side effects include nausea, vomiting, diarrhea, and constipation. Some individuals have also reported experiencing weight loss that is too rapid, potentially leading to nutritional deficiencies
Muscle mass
Retatrutide, like other weight loss medications, can lead to muscle loss alongside fat loss, but studies suggest that the proportion of muscle mass lost with retatrutide is comparable to that seen with lifestyle interventions for obesity. While some muscle loss is a potential side effect of significant weight reduction, retatrutide appears to preserve a reasonable amount of lean mass, especially when combined with strategies to maintain muscle mass
Retatrutide vs mounjaro
Unlike earlier treatments like Wegovy or Mounjaro, which focus on one or two hormone receptors, Retatrutide targets three. This makes it a triple agonist, interacting with the following receptors to promote fat burning, blood sugar control, and appetite reduction: GLP-1 (Glucagon-like peptide 1)
Going by the clinical trial results we have so far, retatrutide may be the most effective weight loss medicine yet. After 48 weeks on retatrutide, people lost up to 24.2% of their body weight. On Mounjaro, the mean loss after 88 weeks was 25.3%
Dosage regime
Once Weekly Dosing Plan:
Starter Dose 4 weeks at 2.5mg
Weeks 5–8 at 5mg
Weeks 9–13 at7.5mg
Weeks 14–18 at 10mg
Research & Development purposes only
15 clicks = 2.5mg
30 clicks = 5mg
45 clicks = 7.5mg
60 clicks = 10mg
